Newsletter | March 8, 2025

03.08.25 -- Clinical Leader Best Of February

FEBRUARY'S BEST FEATURED EDITORIAL

FDA Provides Updated Draft Guidance To Support E6(R3)

Get a quick but thorough understanding of the latest guidance updates with this summary of "E6(R3) Good Clinical Practice: Annex 2."

Annual SCOPE Summit Serves Up A Similar But Satisfying Menu

Executive editor Abby Proch sums up her second SCOPE Summit experience.

What ClinOps Wants To Know About AI

Registrants for our recent Clinical Leader Live, “AI In Action: Transforming Clinical Trials,” were asked what they wanted to learn after watching the webinar. We thought it would be interesting to look at the five general themes to the types of questions they were asking.

FEBRUARY'S BEST INDUSTRY INSIGHTS

What Does 2025 Hold For Pharma?

Look at what’s in store for pharma and life science in 2025. While we see many recurring themes, 2025 promises to be filled with unexpected — and possibly unprecedented — developments.

Improving The Patient Experience In Clinical Research

To preserve the quality of care and build a more effective approach to trial design, a sponsor must consider their approach to patient recruitment and enrollment early and often.

10 Data Linkage Use Cases To Future-Proof Your Clinical Trial

Discover how integrating clinical trial data with real-world data can revolutionize patient insights and enhance evidence generation through ten innovative Medidata Link use cases.

FEBRUARY'S BEST SOLUTIONS

Maximize Your DHT Investment With ActiGraph Scientific Services

Deploy eConsent Around The World With Confidence

AI-Driven Digital Trial Tech Is A "Monumental Breakthrough"

Connect With Clinical Leader: